Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer.
Lorusso V, Carpagnano F, Frasci G, Panza N, Di Rienzo G, Cisternino ML, Napoli G, Orlando S, Cinieri S, Brunetti C, Palazzo S, De Lena M.
Lorusso V, et al. Among authors: frasci g.
J Clin Oncol. 2000 Jan;18(2):405-11. doi: 10.1200/JCO.2000.18.2.405.
J Clin Oncol. 2000.
PMID: 10637256
Clinical Trial.